ORIC Pharmaceuticals Inc
ORIC
Market Cap$338.8M
Close$
$0.85
83.7% downside
Current Fair Value
83.7% downsideOvervalued by 83.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $338.80 Million |
|---|---|
| Enterprise Value | $282.57 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.83 |
| Beta | 1.37 |
| Outstanding Shares | 70,652,013 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.64 |
|---|---|
| PEG | -7.39 |
| Price to Sales | - |
| Price to Book Ratio | 1.74 |
| Enterprise Value to Revenue | 183.73 |
| Enterprise Value to EBIT | -2.09 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About ORIC Pharmaceuticals Inc
CEO: Jacob Chacko